Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

CRDL Stock Forecast, Price Targets, Chart, Dividends & Analysis

Cardiol Therapeutics Inc

Sector: Manufacturing   

Industry: Medicinal and Botanical Manufacturing

1.48
 
USD
  
-0.05
  
(-3.27%)
Previous close: 1.53  Open: 1.52  Bid: 1.44  Ask: 1.5
52 week range    
0.79   
   3.12
Mkt Cap: 125 M  Avg Vol (90 Days): 496,358
Peers   
Last updated: Thursday 5th December 2024

Stock Rankings

15
Technical
21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

CRDL Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles84444.084444.084444.084444.0
Basic EPS from continuing operations-1.03-0.53-0.69-0.73-0.49-0.44
Basic EPS total-1.03-0.53-0.69-0.73-0.49-0.44
Basic weighted shares outstanding15 M26 M30 M43 M63 M64 M
Depreciation7048.066128.0145095.0135464.0
Depreciation unreconciled91492.0150572.0229539.0219908.0
DepreciationAndAmortization91492.0150572.0229539.0219908.0
Diluted EPS total-1.03-0.53-0.69-0.73-0.49-0.44
Diluted normalized net income/share-1.03-0.53-0.69-0.73-0.49-0.44
Diluted weighted shares outstanding15 M26 M30 M43 M63 M64 M
GainOnSaleOfSecurity-8 M-99850.0-34455.07 M
GeneralAndAdministrativeExpense6 M10 M10 M28 M22 M16 M
Income before tax-16 M-14 M-21 M-32 M-36 M-28 M
Interest income103306.0245422.076583.0106001.01 M2 M
InterestExpenseNonOperating663373.0621.0
MiscOtherSpecialCharges164443.0149739.0
Net income from total operations-16 M-14 M-21 M-32 M-36 M-28 M
NetIncomeCommonStockholders-16 M-14 M-21 M-32 M-36 M-28 M
NetIncomeContinuousOperations-16 M-14 M-21 M-32 M-36 M-28 M
NetNonOperatingInterestIncomeExpense560067.0-244801.0-76583.0-106001.01 M2 M
Normalized income-12 M-10 M-15 M-23 M-27 M-21 M
Operating income-7 M-14 M-21 M-39 M-41 M-30 M
Operating income before depreciation (EBITDA)-15 M-14 M-20 M-38 M-36 M-28 M
OperatingExpense7 M14 M21 M39 M41 M30 M
Other income net-8 M198945.0-27057.07 M-6 M-331464.0
OtherGandA6 M10 M10 M28 M22 M16 M
Research & development expense2 M4 M11 M11 M19 M14 M
ResearchExpense19 M14 M
Revenue per share84444.084444.084444.084444.0
SalariesAndWages3 M5 M5 M5 M
SecuritiesAmortization663373.0
Selling Gen & administrative expense6 M10 M10 M28 M22 M16 M
Total Income available for interest expense (EBIT)-15 M-14 M-21 M-32 M-36 M-28 M
Total common shares outstanding23 M26 M33 M61 M43 M
Total net income-16 M-14 M-21 M-32 M-36 M-28 M
Total ordinary shares70 M70 M70 M70 M70 M70 M
Total revenues78760.0
TotalExpenses-7 M-14 M-21 M-39 M
TotalRevenue78760.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University